Repurposing FDA-approved Drugs as Therapeutics to Treat Rift Valley Fever Virus Infection
Frontiers in Microbiology - Switzerland
doi 10.3389/fmicb.2015.00676
Full Text
Open PDFAbstract
Available in full text
Categories
Date
July 8, 2015
Authors
Publisher
Frontiers Media SA